Gene network inference and biochemical assessment delineates GPCR pathways and CREB targets in small intestinal neuroendocrine neoplasia.

Small intestinal (SI) neuroendocrine tumors (NET) are increasing in incidence, however little is known about their biology. High throughput techniques such as inference of gene regulatory networks from microarray experiments can objectively define signaling machinery in this disease. Genome-wide co-...

Full description

Bibliographic Details
Main Authors: Ignat Drozdov, Bernhard Svejda, Bjorn I Gustafsson, Shrikant Mane, Roswitha Pfragner, Mark Kidd, Irvin M Modlin
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2011-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3154895?pdf=render
id doaj-05cdd076561948438e6a5729a09ebe6d
record_format Article
spelling doaj-05cdd076561948438e6a5729a09ebe6d2020-11-25T00:48:33ZengPublic Library of Science (PLoS)PLoS ONE1932-62032011-01-0168e2245710.1371/journal.pone.0022457Gene network inference and biochemical assessment delineates GPCR pathways and CREB targets in small intestinal neuroendocrine neoplasia.Ignat DrozdovBernhard SvejdaBjorn I GustafssonShrikant ManeRoswitha PfragnerMark KiddIrvin M ModlinSmall intestinal (SI) neuroendocrine tumors (NET) are increasing in incidence, however little is known about their biology. High throughput techniques such as inference of gene regulatory networks from microarray experiments can objectively define signaling machinery in this disease. Genome-wide co-expression analysis was used to infer gene relevance network in SI-NETs. The network was confirmed to be non-random, scale-free, and highly modular. Functional analysis of gene co-expression modules revealed processes including 'Nervous system development', 'Immune response', and 'Cell-cycle'. Importantly, gene network topology and differential expression analysis identified over-expression of the GPCR signaling regulators, the cAMP synthetase, ADCY2, and the protein kinase A, PRKAR1A. Seven CREB response element (CRE) transcripts associated with proliferation and secretion: BEX1, BICD1, CHGB, CPE, GABRB3, SCG2 and SCG3 as well as ADCY2 and PRKAR1A were measured in an independent SI dataset (n = 10 NETs; n = 8 normal preparations). All were up-regulated (p<0.035) with the exception of SCG3 which was not differently expressed. Forskolin (a direct cAMP activator, 10(-5) M) significantly stimulated transcription of pCREB and 3/7 CREB targets, isoproterenol (a selective ß-adrenergic receptor agonist and cAMP activator, 10(-5) M) stimulated pCREB and 4/7 targets while BIM-53061 (a dopamine D(2) and Serotonin [5-HT(2)] receptor agonist, 10(-6) M) stimulated 100% of targets as well as pCREB; CRE transcription correlated with the levels of cAMP accumulation and PKA activity; BIM-53061 stimulated the highest levels of cAMP and PKA (2.8-fold and 2.5-fold vs. 1.8-2-fold for isoproterenol and forskolin). Gene network inference and graph topology analysis in SI NETs suggests that SI NETs express neural GPCRs that activate different CRE targets associated with proliferation and secretion. In vitro studies, in a model NET cell system, confirmed that transcriptional effects are signaled through the cAMP/PKA/pCREB signaling pathway and that a SI NET cell line was most sensitive to a D(2) and 5-HT(2) receptor agonist BIM-53061.http://europepmc.org/articles/PMC3154895?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Ignat Drozdov
Bernhard Svejda
Bjorn I Gustafsson
Shrikant Mane
Roswitha Pfragner
Mark Kidd
Irvin M Modlin
spellingShingle Ignat Drozdov
Bernhard Svejda
Bjorn I Gustafsson
Shrikant Mane
Roswitha Pfragner
Mark Kidd
Irvin M Modlin
Gene network inference and biochemical assessment delineates GPCR pathways and CREB targets in small intestinal neuroendocrine neoplasia.
PLoS ONE
author_facet Ignat Drozdov
Bernhard Svejda
Bjorn I Gustafsson
Shrikant Mane
Roswitha Pfragner
Mark Kidd
Irvin M Modlin
author_sort Ignat Drozdov
title Gene network inference and biochemical assessment delineates GPCR pathways and CREB targets in small intestinal neuroendocrine neoplasia.
title_short Gene network inference and biochemical assessment delineates GPCR pathways and CREB targets in small intestinal neuroendocrine neoplasia.
title_full Gene network inference and biochemical assessment delineates GPCR pathways and CREB targets in small intestinal neuroendocrine neoplasia.
title_fullStr Gene network inference and biochemical assessment delineates GPCR pathways and CREB targets in small intestinal neuroendocrine neoplasia.
title_full_unstemmed Gene network inference and biochemical assessment delineates GPCR pathways and CREB targets in small intestinal neuroendocrine neoplasia.
title_sort gene network inference and biochemical assessment delineates gpcr pathways and creb targets in small intestinal neuroendocrine neoplasia.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2011-01-01
description Small intestinal (SI) neuroendocrine tumors (NET) are increasing in incidence, however little is known about their biology. High throughput techniques such as inference of gene regulatory networks from microarray experiments can objectively define signaling machinery in this disease. Genome-wide co-expression analysis was used to infer gene relevance network in SI-NETs. The network was confirmed to be non-random, scale-free, and highly modular. Functional analysis of gene co-expression modules revealed processes including 'Nervous system development', 'Immune response', and 'Cell-cycle'. Importantly, gene network topology and differential expression analysis identified over-expression of the GPCR signaling regulators, the cAMP synthetase, ADCY2, and the protein kinase A, PRKAR1A. Seven CREB response element (CRE) transcripts associated with proliferation and secretion: BEX1, BICD1, CHGB, CPE, GABRB3, SCG2 and SCG3 as well as ADCY2 and PRKAR1A were measured in an independent SI dataset (n = 10 NETs; n = 8 normal preparations). All were up-regulated (p<0.035) with the exception of SCG3 which was not differently expressed. Forskolin (a direct cAMP activator, 10(-5) M) significantly stimulated transcription of pCREB and 3/7 CREB targets, isoproterenol (a selective ß-adrenergic receptor agonist and cAMP activator, 10(-5) M) stimulated pCREB and 4/7 targets while BIM-53061 (a dopamine D(2) and Serotonin [5-HT(2)] receptor agonist, 10(-6) M) stimulated 100% of targets as well as pCREB; CRE transcription correlated with the levels of cAMP accumulation and PKA activity; BIM-53061 stimulated the highest levels of cAMP and PKA (2.8-fold and 2.5-fold vs. 1.8-2-fold for isoproterenol and forskolin). Gene network inference and graph topology analysis in SI NETs suggests that SI NETs express neural GPCRs that activate different CRE targets associated with proliferation and secretion. In vitro studies, in a model NET cell system, confirmed that transcriptional effects are signaled through the cAMP/PKA/pCREB signaling pathway and that a SI NET cell line was most sensitive to a D(2) and 5-HT(2) receptor agonist BIM-53061.
url http://europepmc.org/articles/PMC3154895?pdf=render
work_keys_str_mv AT ignatdrozdov genenetworkinferenceandbiochemicalassessmentdelineatesgpcrpathwaysandcrebtargetsinsmallintestinalneuroendocrineneoplasia
AT bernhardsvejda genenetworkinferenceandbiochemicalassessmentdelineatesgpcrpathwaysandcrebtargetsinsmallintestinalneuroendocrineneoplasia
AT bjornigustafsson genenetworkinferenceandbiochemicalassessmentdelineatesgpcrpathwaysandcrebtargetsinsmallintestinalneuroendocrineneoplasia
AT shrikantmane genenetworkinferenceandbiochemicalassessmentdelineatesgpcrpathwaysandcrebtargetsinsmallintestinalneuroendocrineneoplasia
AT roswithapfragner genenetworkinferenceandbiochemicalassessmentdelineatesgpcrpathwaysandcrebtargetsinsmallintestinalneuroendocrineneoplasia
AT markkidd genenetworkinferenceandbiochemicalassessmentdelineatesgpcrpathwaysandcrebtargetsinsmallintestinalneuroendocrineneoplasia
AT irvinmmodlin genenetworkinferenceandbiochemicalassessmentdelineatesgpcrpathwaysandcrebtargetsinsmallintestinalneuroendocrineneoplasia
_version_ 1725255607850631168